Bayer CropScience Ltd
₹4520.60
(-1.82%)
Fri, 13 Mar 2026, 04:20 am
Bayer CropScience Ratios
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 24.83 | 18.85 | 24.94 | 10.43 | 20.18 | 27.53 | 22.80 | 4.10 | 20.06 | 31.80 | 43.15 | 46.09 | 48.78 | 55.88 | 32.76 | 48.36 | 34.70 | 23.99 | 31.82 | 38.99 |
| Price to book ratio | 3.29 | 3.13 | 2.48 | 2.18 | 4.59 | 5.38 | 4 | 2.46 | 3.17 | 5.99 | 7.24 | 6.52 | 8.11 | 6.72 | 6.04 | 9.35 | 8.87 | 6.71 | 8.27 | 7.77 |
| Price to sales ratio | 1.45 | 1.45 | 1 | 0.72 | 1.58 | 1.78 | 1.44 | 1.81 | 1.88 | 3.43 | 4.91 | 4.79 | 5.40 | 5.95 | 4.31 | 5.60 | 4.73 | 3.54 | 4.62 | 4.05 |
| Price to cash flow ratio | 0 | 34.03 | 6.60 | 37.65 | 35.97 | 30.53 | 25.75 | 26.04 | 16.15 | 46.29 | 52.03 | 65.18 | 102.59 | 41.30 | 22.39 | 33.45 | 96.81 | 29.19 | 24.19 | 73.77 |
| Enterprise value | 10.41B | 11.29B | 9.56B | 10.09B | 26.67B | 34.53B | 27.4B | 37.85B | 53.14B | 110.21B | 127.96B | 125.25B | 142.22B | 182.56B | 144.78B | 226.09B | 216.53B | 173.57B | 223.93B | 213.21B |
| Enterprise value to EBITDA ratio | 6.82 | 18.94 | 51.78 | 11.73 | 19.57 | 12.71 | 8.03 | 8.85 | 16.22 | 26.17 | 28.58 | 29.23 | 33.66 | 36.14 | 19.71 | 27.51 | 26.04 | 18.33 | 22.44 | 29.82 |
| Debt to equity ratio | 0.42 | 0.34 | 0.19 | 0.09 | 0.20 | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.03 | 0.03 | 0.02 | 0.04 |
| Return on equity % | 13.93 | 17.78 | 10.45 | 23.03 | 25.18 | 21.34 | 18.97 | 85.29 | 15.76 | 20.29 | 16.27 | 15.27 | 15.65 | 16.78 | 21.30 | 19.25 | 25.43 | 28.96 | 26.63 | 19.93 |
Bayer CropScience Ltd Ratios
The Bayer CropScience Ltd Ratios page provides a complete fundamental analysis of Bayer CropScience Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Bayer CropScience Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Bayer CropScience Ltd (NSE: BAYERCROP, BSE: 506285) is currently trading at ₹4520.60, with a market capitalization of ₹206.93B. As a major player in the Process industries sector and Chemicals: agricultural industry, Bayer CropScience Ltd remains a key stock for fundamental analysis using Bayer CropScience Ltd Ratios.
Bayer CropScience Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Bayer CropScience Ltd P/E ratio currently stands at 38.99, making it one of the most tracked metrics in Bayer CropScience Ltd Ratios.
Historically, the Bayer CropScience Ltd P/E ratio has shown strong fluctuations:
- 2024: 38.99
- 2023: 31.82
- 2022: 23.99
- 2021: 34.70
- 2020: 48.36
The rising Bayer CropScience Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The Bayer CropScience Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 7.77.
Historical P/B trend:
- 2024: 7.77
- 2023: 8.27
- 2022: 6.71
- 2021: 8.87
Bayer CropScience Ltd is trading at a premium to its book value, indicating strong market confidence.
Price to Sales Ratio (P/S)
The Bayer CropScience Ltd P/S ratio currently stands at 4.05, an important part of Bayer CropScience Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 4.05
- 2023: 4.62
- 2022: 3.54
- 2021: 4.73
A stable or declining Bayer CropScience Ltd P/S ratio indicates cautious market sentiment.
Bayer CropScience Ltd Price to Cash Flow Ratio (P/CF)
The Bayer CropScience Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 73.77.
Historical Bayer CropScience Ltd Price to Cash Flow Ratio:
- 2024: 73.77
- 2023: 24.19
- 2022: 29.19
- 2021: 96.81
- 2020: 33.45
The rising Bayer CropScience Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.
Bayer CropScience Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Bayer CropScience Ltd EV currently stands at ₹213.21B, representing the total company valuation including debt.
Historical EV trend:
- 2024: 213.21B
- 2023: 223.93B
- 2022: 173.57B
- 2021: 216.53B
Bayer CropScience Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Bayer CropScience Ltd EV/EBITDA ratio is currently 29.82, a key metric in Bayer CropScience Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 29.82
- 2023: 22.44
- 2022: 18.33
- 2021: 26.04
Higher Bayer CropScience Ltd EV/EBITDA suggests premium valuation.
Bayer CropScience Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Bayer CropScience Ltd D/E ratio is currently 0.04, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.04
- 2023: 0.02
- 2022: 0.03
- 2021: 0.03
Bayer CropScience Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Bayer CropScience Ltd ROE currently stands at 19.93%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 19.93
- 2023: 26.63
- 2022: 28.96
- 2021: 25.43
Bayer CropScience Ltd maintains stable profitability levels.
Bayer CropScience Ltd Ratios Analysis Summary
The Bayer CropScience Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Bayer CropScience Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Bayer CropScience Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800